Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a progressively debilitating neurodegenerative disease characterized by α-synucleinopathy, which involves all districts of the brain-gut axis, including the central, autonomic and enteric nervous systems. The highly bidirectional communication between the brain and the gut is markedly influenced by the microbiome through integrated immunological, neuroendocrine and neurological processes. The gut microbiota and its relevant metabolites interact with the host via a series of biochemical and functional inputs, thereby affecting host homeostasis and health. Indeed, a dysregulated microbiota-gut-brain axis in PD might lie at the basis of gastrointestinal dysfunctions which predominantly emerge many years prior to the diagnosis, corroborating the theory that the pathological process is spread from the gut to the brain. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs primarily found in microorganisms and a dysregulation in their signaling may be implicated in α-synucleinopathy, such as PD. An overstimulation of the innate immune system due to gut dysbiosis and/or small intestinal bacterial overgrowth, together with higher intestinal barrier permeability, may provoke local and systemic inflammation as well as enteric neuroglial activation, ultimately triggering the development of alpha-synuclein pathology. In this review, we provide the current knowledge regarding the relationship between the microbiota-gut–brain axis and TLRs in PD. A better understanding of the dialogue sustained by the microbiota-gut-brain axis and innate immunity via TLR signaling should bring interesting insights in the pathophysiology of PD and provide novel dietary and/or therapeutic measures aimed at shaping the gut microbiota composition, improving the intestinal epithelial barrier function and balancing the innate immune response in PD patients, in order to influence the early phases of the following neurodegenerative cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systemic inflammation induced by intestinal inflammation and barrier disruption is key in gut–brain communication [57,58,59].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [59]
In the citing paper
“Gut dysbiosis and the consequent development of pathogenic populations within the gut microbiota, may contribute to a wide variety of pathologies, even in sites distant from the gut, ranging from bowel inflammation, to neurodegenerative diseases (including Parkinson’s disease) and cancer [43,49,50].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haddadi, R., Nayebi, A. M., & Brooshghalan, S. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.020 · Cited by 39
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Cited by
Items 101–200 of 350
Zapała, B., Stefura, T., Wójcik-Pędziwiatr, M., Kabut, R., Bałajewicz-Nowak, M., Milewicz, T., Dudek, A., Stój, A., & Rudzińska-Bar, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235698 · Cited by 44
“As mentioned, colonic inflammation was identified in over 80% of PD cases, and they precede the motor symptoms even by several years [8].”
BackgroundThe sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou-El-Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 42
“This dysbiosis is hypothesized to stimulate the innate immune system and trigger inflammation-induced misfolding of α-Synuclein and thus PD pathology (Caputi and Giron, 2018; Keshavarzian et al., 2015; Petrov et al., 2017).”
BackgroundNutraceuticals: An integrative approach to starve Parkinson’s disease
Lama, A., Pirozzi, C., Avagliano, C., Annunziata, C., Mollica, M. P., Calignano, A., Meli, R., & Raso, G. M. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100037 · Cited by 45
“It has been demonstrated that asiatic acid, a pentacyclic triterpene naturally occurring in medicinal plants, including Centella asiatica, was able to reduce striatal inflammation in MPTP-challenged mice, reducing inflammatory cytokines, TLR2, TLR4, and NF-κB expression (Chao et al., 2016).”
BackgroundGut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment
Li, H., Ni, J., & Qing, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.671142 · Cited by 47
Bacteriotherapy in gastrointestinal cancer
Soleimanpour, S., Hasanian, S. M., Avan, A., Yaghoubi, A., & Khazaei, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117754 · Cited by 47
Is Porphyromonas gingivalis involved in Parkinson’s disease?
Olsen, I., Kell, D. B., & Pretorius, E. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03944-2 · Cited by 46
Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-230206 · Cited by 40
“…immune and enteric glial cells, which together with higher intestinal barrier permeability further provokes local and systemic inflammation and enteric neuroglial activation, triggering the development of (cid:2) -syn pathology and ultimately not only gut, but also brain inflammation [113, 145–150].”
BackgroundTian, X.-Y., Dong, W., Zhou, W., Yan, Y., Lu, L., Mi, J., Cao, Y., Sun, Y., & Zeng, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129036 · Cited by 42
Bashir, B., Alam, S., Khandale, N. B., Birla, D., Vishwas, S., Pandey, N. K., Gupta, G., Paudel, K. R., Dureja, H., Kumar, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102236 · Cited by 40
Mycotoxins and the Enteric Nervous System
Gonkowski, S., Gajęcka, M., & Makowska, K. (2020) · Toxins · doi:10.3390/toxins12070461 · Cited by 45
A Narrative Review on the Advance of Probiotics to Metabiotics
Jang, H. J., Lee, N., & Paik, H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2311.11023 · Cited by 43
“Intestinal bacteria are known to have the ability to produce numerous neuroactive molecules such as serotonin, gamma amino butyric acid (GABA) and SCFAs [52].”
BackgroundZhong, L., Cai, B., Wang, Q., Li, X., Xu, W., & Chen, T. (2022) · Pharmaceuticals · doi:10.3390/ph16010039 · Cited by 40
Ketone Bodies and Brain Metabolism: New Insights and Perspectives for Neurological Diseases
López-Ojeda, W., & Hurley, R. A. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230017 · Cited by 41
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Atabati, H., Yazdanpanah, E., Mortazavi, H., Bajestani, S. G., Raoofi, A., Esmaeili, S., Khaledi, A., Saburi, E., Afshari, J. T., Sathyapalan, T., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_6 · Cited by 40
The neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 39
“It was also demonstrated that Prevotella spp. are involved in mucin synthesis and short-chain fatty acid (SCFA) production (Caputi and Giron, 2018), which may suggest that the lack of Prevotella spp. is likely associated with reduced mucin synthesis and increased gut permeability (Forsyth et al.,…”
Li, C., Chen, Y., Wen, Y. F., Jia, Y., Cheng, S., Liu, L., Zhang, H., Pan, C., Zhang, J., Zhang, Z., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.960756 · Cited by 53
What is strain in neurodegenerative diseases?
Tian, Y., Meng, L., & Zhang, Z. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03298-9 · Cited by 37
“Some animal experiments were conducted to indicate the converse propagation of the intestinal α-synuclein inclusions to the CNS along the vagus nerve, supporting the gut–brain axis hypothesis of PD [76].”
BackgroundGut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
“Microbial metabolites have been demonstrated to interact with these TLRs inducing not only elevated local inflammation but also dysfunction in clearance of α-Syn pathogenic species (Caputi and Giron 2018).”
BackgroundGhrelin as a prominent endocrine factor in stress-induced obesity
van Loenen, M. R., Geenen, B., Arnoldussen, I. A. C., & Kiliaan, A. J. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1863740 · Cited by 45
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10081544 · Cited by 39
Huang, T., Shi, H., Xu, Y., & Ji, L. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001585 · Cited by 36
Li, X., Tong, H., Xu, S., Zhou, G., Yang, T., Yin, S., Yang, S., Li, X., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111787 · Cited by 36
“In the case of gut dysbiosis, key immune changes include functional modulation of dendritic cells and glial cells in the CNS, as well as functional modulation of host immune cells such as effector T cells and B cells in the gut, peripheral blood, and peripheral nervous system [99].”
BackgroundSingh, Y., El-Hadidi, M. S., Admard, J., Wassouf, Z., Schulze-Hentrich, J. M., Kohlhofer, U., Quintanilla‐Martínez, L., Huson, D. H., Rieß, O., & Casadei, N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01032 · Cited by 35
“Thus, in addition to the genetic factors, external or unknown internal factors inducing α-Syn aggregation or expression such as environmental conditions, diet or lifestyle, bacterial metabolites and self-antigens may also trigger or enhance PD (Yamin et al., 2003; Bischoff et al., 2014; Klingelhoefer and Reichmann, 20…”
Backgroundvan Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 40
“elicits neuroprotective effects in PD, particularly because it restores gut microbiota balance, due to the reduction in Firmicutes and Bacteroidetes bacteria [25].”
BackgroundBeyond the Brain: Exploring the multi-organ axes in Parkinson’s disease pathogenesis
Liu, T., Wu, H., & Wei, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.034 · Cited by 36
“These inflammatory factors can be transported to the brain through blood circulation, activating microglial cells, initiating neuroin-flammatory responses, damaging dopaminergic neurons, and promoting the progression of PD [234,235].”
Baj, J., Sitarz, R., Forma, A., Wróblewska, K., & Karakuła‐Juchnowicz, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041476 · Cited by 37
Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells
Conte, C., Sichetti, M., & Traina, G. (2020) · Applied Sciences · doi:10.3390/app10051828 · Cited by 34
“Commensal microbiota and microbial metabolites are sensed by Toll-like receptors (TLRs), the most extensively characterized class of pattern-recognition receptors (PRRs), via which the innate immune system in the gut recognizes pathogen-associated molecular patterns (PAMPs) and endogenous molecules generated by damage…”
BackgroundNutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review
Lister, T. (2020) · Journal of Movement Disorders · doi:10.14802/jmd.20006 · Cited by 35
The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease
Natale, G., Ryskalin, L., Morucci, G., Lazzeri, G., Frati, A., & Fornai, F. (2021) · Life · doi:10.3390/life11080732 · Cited by 36
“A dysregulation of Toll-like receptor signaling is also implicated in the pathogenesis of α-synucleinopathies [83].”
BackgroundMarć, M. A., Jastrząb, R., & Mytych, J. (2022) · Nutrients · doi:10.3390/nu14193967 · Cited by 36
“It has been confirmed that gut dysbiosis can augment intestinal permeability and bacterial translocation, causing an over-response of the immune system and the subsequent systemic/central nervous system inflammation [39,40].”
BackgroundSun, L., Jiang, W.-W., Wang, Y., Yuan, Y.-S., Rong, Z., Wu, J., Fan, Y., Lu, M., & Zhang, K.-Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00676-w · Cited by 31
“TLRs can recognize different pathogen-associated molecular patterns and damage-associated molecular patterns triggering downstream cascades [34, 35].”
Li, S., Zhu, X., & Xing, M. (2019) · Marine Drugs · doi:10.3390/md17110599 · Cited by 31
“Some research exhibited how gut microbiota or potential probiotics can exert therapeutic interventions by decreasing gut permeability or stimulating host homeostasis of the mucosal immune system and then regulating microbiota dysbiosis to a healthy state [23].”
BackgroundRole of Maternal Microbiota and Nutrition in Early-Life Neurodevelopmental Disorders
Daliry, A., & Pereira, E. N. G. D. S. (2021) · Nutrients · doi:10.3390/nu13103533 · Cited by 34
Li, M., Wang, S., Zhang, C., Chi, C., Liu, R., Wang, T., & Fu, F.-H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109659 · Cited by 31
Fongang, B., Satizábal, C. L., Kautz, T. F., Wadop, Y. N., Muhammad, J. A. S., Vasquez, E. L., Mathews, J. J., Gireud, M., Saklad, A. R., Himali, J. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40872-5 · Cited by 33
The role of the gut microbiome in disorders of gut–brain interaction
Gawey, B. J., Mars, R. A. T., & Kashyap, P. (2024) · FEBS Journal · doi:10.1111/febs.17200 · Cited by 32
“Bacterial activation of TLRs can induce proinflam-matory cytokine production and subsequent inflamma-tory reactions [136 – 138].”
Nielsen, S. D., Pearson, N. M., & Seidler, K. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147609 · Cited by 37
Riegelman, E., Xue, K. S., Wang, J.-S., & Tang, L. (2024) · Nutrients · doi:10.3390/nu16132041 · Cited by 36
Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis
Harsányiová, J., Buday, T., & Trancikova, A. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00626 · Cited by 31
“, 2018), while GIT disorders often result in CNS-related symptoms (Caputi and Giron, 2018).”
BackgroundChakraborty, P., Aravindhan, V., & Mukherjee, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124649 · Cited by 29
Cai, X., Wijesekara, T., & Xu, B. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.10.010 · Cited by 29
Clark, I., & Vissel, B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201186 · Cited by 27
“In addition, the role of the gut microbiome in the development of AD and PD is nowadays expressed in terms of overstimulation of innate immunity by PAMPs of bacterial origin [180, 181].”
BackgroundInflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Garmendia, J. V., Sanctis, C. V. D., Das, V., Annadurai, N., Hajdúch, M., & Sanctis, J. B. D. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231017141636 · Cited by 30
“An increased amount of complement cascade molecules has been reported in the plasma, CSF, and brain tissues of patients with NDs [42]; for example, in PD patients, complement molecules are increased along with inflammatory cytokines [43].”
BackgroundAtilano, M. L., Hull, A. J., Romila, C.-A., Adams, M. L., Wildfire, J., Ureña, E., Dyson, M. C., Castillo-Quan, J. I., Partridge, L., & Kinghorn, K. J. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1011063 · Cited by 29
Chen, H., Chung, Y.-C. E., Chen, H., Liu, Y.-W., Chen, I., Lu, M., Hsiao, F. S., Chen, C.-H., Huang, M., Shih, W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24773-7 · Cited by 28
Role of Helicobacter pylori infection in the manifestation of old age‐related diseases
Zendehdel, A., & Roham, M. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1157 · Cited by 30
Zhang, X., Svn, Z., Liv, M., Yan, Y., Zeng, R., Huang, Q., & Sun, Q. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.720958 · Cited by 27
“When intestinal dysfunction and/or intestinal flora are disturbed, it may cause local and systemic inflammation and enteric neuroglial activation, which will eventually trigger the development of αsynuclein pathology (13, 39).”
BackgroundOverview of the Gut–Brain Axis: From Gut to Brain and Back Again
Post, Z., Manfready, R. A., & Keshavarzian, A. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771464 · Cited by 30
Song, S., Liu, J., Zhang, F., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-72202-4 · Cited by 27
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
“Interestingly, TLR overstimulation has also been suggested in PD pathology (274).”
BackgroundZhao, R., Mu, B., Wang, D., XinHuang, Ma, Q., & Lu, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04584-9 · Cited by 30
“…including the gut and central neural network, neuroendocrine-hypothalamic–pituitary–adrenal axis system, immune system, neurotransmitters and neuromodulators produced by the gut microbiota, and barrier pathways such as the intestinal mucosal barrier and the blood–brain barrier (BBB) [12].”
Stress and the Gut-Brain Axis: Implications for Cancer, Inflammation and Sepsis
Moughnyeh, M., Brawner, K. M., Kennedy, B. A., Yeramilli, V. A., Udayakumar, N., Graham, J. A., & Martin, C. A. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.02.055 · Cited by 24
Brogna, C., Cristoni, S., Brogna, B., Bisaccia, D. R., Giuliano, M., Viduto, V., Montano, L., & Piscopo, M. (2022) · Biomedicines · doi:10.3390/biomedicines11010087 · Cited by 24
“On the other hand, many papers show the connection between PD [19,20] or AD [20,21], and the gut microbiome.”
BackgroundMa, Y.-F., Lin, Y.-A., Huang, C.-L., Hsu, C.-C., Wang, S. Z., Yeh, S., & Tsai, Y.-C. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09828-x · Cited by 25
Pathogenesis from the microbial-gut-brain axis in white matter injury in preterm infants: A review
Wang, Y., Zhu, J., Zou, N., Zhang, L., Wang, Y., Zhang, M., Wang, C., & Yang, L. L. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2023.1051689 · Cited by 25
“In PD model mice, probiotics can be used to restore the ecological imbalance of intestinal microorganisms, and the gut-brain axis can act on the brain to reduce anxiety and depressive behaviors and improve cognitive function (Caputi and Giron, 2018; Sun and Shen, 2018).”
BackgroundGut Microbiota and Endocrine Disorder
Li, R., Li, Y., Cui, L., Zheng, D., & Chen, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_9 · Cited by 24
Jia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22
Balakrishnan, R., Kang, S.-I., Lee, J. Y., Rho, Y., Kim, B.-K., & Choi, D. (2024) · Aging and Disease · doi:10.14336/ad.2024.1362 · Cited by 39
“…along with their metabolic byproducts, engage in continuous interactions with PRRs expressed on peripheral blood immune cells, intestinal epithelial cells (IECs), blood endothelial cells (ECs), as well as neurons and glial cells (microglia and astrocytes) located within both the CNS and PNS [103].”
How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
Zhang, Z., Liu, Z., Lv, A., & Fan, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1154626 · Cited by 27
“When bacteria break through the natural physical protective barriers of the human body, such as skin and mucous membranes, Toll-like receptors can recognize and stimulate the human body to form an immune response (79).”
BackgroundExploring Risk and Protective Factors in Parkinson’s Disease
Beheshti, I. (2025) · Cells · doi:10.3390/cells14100710 · Cited by 22
“Additionally, the gut microbiota influences immune responses through toll-like receptors, and dysregulation of these receptors can contribute to alpha-synuclein pathology [157].”
Effect of Microbiota in the Development of Breast Cancer.
Hussein, A. S., Salih, N. I., & Saadoon, I. H. (2021) · PubMed · doi:10.22092/ari.2021.355961.1750 · Cited by 23
“The microbiota has a role in a variety of diseases, including metabolic disorders, inflammatory and autoimmune diseases, allergies, and even conditions where microbiome involvement appears implausible (3-5).”
BackgroundEnteric Nervous System and Its Relationship with Neurological Diseases
Bartolomé, M. J. L., López-Marco, L., Monzón, M., & Santander, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185579 · Cited by 20
“TLR activation promotes inflammation and oxidative stress, suggesting that their use as a therapeutic target could improve gut health, restore epithelial barrier function, and mitigate excessive immune response, thus preventing the neurodegenerative process [24].”
BackgroundThe microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease
Izzeddine, N. A., Ahmad, K., Bacha, C., Jabbour, M., Najjar, M., Salhab, S., Ghadieh, H. E., Kanaan, A., Azar, S. T., Khattar, Z. A., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.014 · Cited by 23
“Furthermore, decreased levels of the intestinal hormone ghrelin, which regulates nigrostriatal dopamine activity, have been associated with higher Lactobacilllaceae and lower Prevotellaceae abundance in the gut microbiome (Caputi and Giron, 2018).”
Intestinal tryptophan metabolism in disease prevention and swine production
Hu, Z., Feng, L., Jiang, Q., Wang, W., Tan, B., Tang, X., & Yin, Y. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.08.002 · Cited by 21
Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J. (2023) · Epigenomics · doi:10.2217/epi-2023-0342 · Cited by 22
Liu, R. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1266510 · Cited by 20
“…have specific immunomodulatory functions, with some proteins inducing the proliferation and differentiation of immune cells and nucleic acid molecules enhancing the function of the intestinal barrier by binding to Toll-like receptors in intestinal epithelial cells (Caputi and Giron, 2018).”
Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050465 · Cited by 20
“These observations may also extend to higher center via the so-called gut–brain axis and help to decipher novel therapeutic strategies in an area of active investigation, represented by central nervous system disorders associated to gastrointestinal dysfunction or vice versa [43,51,63].”
BackgroundSelf-citationKawano, M., Saika, K., Takagi, R., Matsui, M., & Matsushita, S. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100071 · Cited by 20
Chen, Y., Wan, M., Zhong, Y., Gao, T., Zhang, Y., Yan, F., Huang, D., Wu, Y., & Weng, Z. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100146 · Cited by 20
Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities
Xi, Y., Wang, Z., Wei, Y., Xiao, N., Duan, L., Zhao, T., Zhang, X., Zhang, L., Wang, J., Li, Z., et al. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2550003x · Cited by 18
Tumpa, J. J., Hayder, Q. U. A., Maisa, N. S., & Islam, M. N. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1682006 · Cited by 18
“In addition to maintaining gut homeostasis, the gut microbiota is also responsible for stimulating toll-like receptor (TLR) ligands (Caputi and Giron, 2018).”
Shi, J., Mao, C., Guo, Y.-Z., Fan, Y., Hao, X.-Y., Li, S., Tian, J., Hu, Z., Li, M., Li, J.-D., et al. (2024) · Aging · doi:10.18632/aging.205444 · Cited by 18
“There exists a hypothesis positing the spread of the pathological process from the gastro-intestinal tract to the brain [29, 30], while the existing studies did not systematically evaluate tissues besides the CNS, especially in the digestive system.”
BackgroundWang, J., Wang, X., Luo, H., Xie, Y., Cao, H., Mao, L., Liu, T., Yue, Y., & Qian, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02074-6 · Cited by 20
Molina, B., Mastroianni, J., Suarez, E., Soni, B., Forsberg, E. M., & Finley, K. D. (2021) · Cells · doi:10.3390/cells10040900 · Cited by 18
“However, the nature of these studies fails to address the complex, whole animal, real-time interactions that bacteriologics may have with the gut–brain axis [3,29,30,48,55].”
InfluentialMa, X., Wang, Q., Yuan, W., Wang, Y., Zhou, F., Kang, K., Tong, X., & Liu, Z. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab046 · Cited by 20
The Microbiome–Gut–Brain Axis and Dementia: A Bibliometric Analysis
Sun, H., Feng, Y., Zhang, Q., Li, J., Wang, Y., Su, Z., Cheung, T. C. C., Jackson, T., Sha, S., & Xiang, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416549 · Cited by 21
“As another high frequency keyword, “Parkinson’s disease” (PD) is a progressive neurodegenerative disorder displaying an altered α-synucleinopathy that may be distributed along the brain–gut axis [57].”
BackgroundZhuo, Y., Li, X., He, Z., & Lu, M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03280-0 · Cited by 19
“Microglia are macrophage-like populations of the central nervous system, which remain quiescent until injury or infection activates the cells to perform inflammatory functions and antigen-presenting cell (APC) functions [31].”
BackgroundXu, Y., Zhao, Y., Liang, L. R., Qu, Y., Yu, C., Zhang, J., Lian, W., & Zhao, Y. C. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107409 · Cited by 17
Campisciano, G., & Biffi, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12511 · Cited by 19
“This bidirectional communication includes the triad microbiota-gut-brain, linked with neuropsychiatric disorders and neurologic diseases [59, 60, 61].”
BackgroundJiao, B., Ouyang, Z., Liu, Q., Xu, T., Wan, M., Ma, G., Zhou, L., Guo, J., Wang, J., Tang, B., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331434 · Cited by 19
Zhang, M., Wang, Y., Wu, Y., Li, F., Han, M., Dai, Y., Zheng, F. Y., & Yue, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/1735803 · Cited by 17
“-is result is consistent with the research results of Valentina and Cecilia [13].”
Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
Basellini, M. J., Kothuis, J. M., Comincini, A., Pezzoli, G., Cappelletti, G., & Mazzetti, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802033 · Cited by 21
“Studies in vitro and in animal models suggest that the extracellular aggregated and misfolded alpha-synuclein is recognized by microglial Toll-Like receptors, triggering protein uptake, microglial activation and inflammatory response prior to neuronal loss [ 152].”
BackgroundAi, P., Xu, S., Yuan, Y., Xu, Z., He, X., Mo, C., Zhang, Y., Yang, X., & Xiao, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115282 · Cited by 17
“Studies suggest that PD patients exhibit distinct microbiota compositions compared to healthy individuals [7].”
He, Z.-Q., Huan, P.-F., Wang, L., & He, J. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04004-9 · Cited by 19
“Given that gut dysbiosis could promote inflammation as well as oxidative stress in the brain of PD patients and trigger the excessive response of the immune system accompanied by systemic inflammation [11].”
BackgroundGut-brain axis interacts with immunomodulation in inflammatory bowel disease
Ye, X., Zhang, M., Zhang, N., Wei, H., & Wang, B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115949 · Cited by 16
Dai, R., Huang, J., Cui, L., Sun, R., Qiu, X., Wang, Y., & Sun, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282694 · Cited by 15
“Altered interactions of the gut – brain microbiota are inclined to cause well-known gut – brain disorders bidirectionally (8, 9) and prone to mediate the pathogenesis of several brain diseases encompassing Parkinson ’ s disease and emotional disorders (10, 11).”
BackgroundLiang, L., Li, S., Huang, Y., Zhou, J., Xiong, D., Li, S., Li, H., Zhu, B., Li, X., Ning, Y., et al. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103567 · Cited by 17
“Recently, a number of studies have indicated that the abundance of gut microbiome was significantly correlated with the brain structure and function in patients with SZ [4, 5] , major depressive disorder [6, 7] , Alzheimer’s disease [8-10] and Parkinson’s disease [11-13] .”
BackgroundYao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 16
“However, despite the existence of intestinal dysmotility and intestinal dysbiosis in PD patients, it remains unclear whether these conditions precede one another and the exact mechanisms by which the gut and its microbiota influence the progression of PD [93, 94].”
Wu, Y., Kuang, G., Lu, F.-G., Wang, H.-X., Lu, M. M., & Zhou, Q. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3224-2 · Cited by 18
Comparative Analysis of Multiple Neurodegenerative Diseases Based on Advanced Epigenetic Aging Brain
Shi, F., He, Y., Chen, Y., Yin, X., Sha, X., & Wang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.657636 · Cited by 19
Milmed Yeast Alters the LPS-Induced M1 Microglia Cells to Form M2 Anti-Inflammatory Phenotype
Armeli, F., Mengoni, B., Maggi, E., Mazzoni, C., Preziosi, A., Mancini, P., Businaro, R., Lenz, T., & Archer, T. (2022) · Biomedicines · doi:10.3390/biomedicines10123116 · Cited by 15
“In addition, perturbations to the gut microbiota were detected in neurodegenerative conditions such as Parkinson’s disease (PD) [9] and Alzheimer’s disease (AD) [10], a complex community of microorganisms influenced not only by host genetics, but also by diet and the environment [11].”
BackgroundTLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
He, Y., Zhao, J., Dong, H., Zhang, X., Duan, Y., Ma, Y., Yu, M., Fei, J., & Huang, F. P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122171 · Cited by 16
Shevchenko, S., Radey, M. C., Tchesnokova, V. L., Kisiela, D., & Sokurenko, E. V. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01866-19 · Cited by 14
The roles and mechanisms of gut microbiome and metabolome in patients with cerebral infarction
Qian, W., Wu, M., Qian, T.-T., Xie, C., Gao, Y., & Qian, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1112148 · Cited by 14
“Several studies have shown that the gut-brain axis plays an important role in various neurological diseases such as Parkinson ’s disease (PD), Alzheimer’s disease (AD), and cerebrovascular diseases (Caputi and Giron, 2018; Megur et al., 2020).”
BackgroundGrahl, M. V. C., Andrade, B. D. S., Perin, A. P. A., Neves, G. A., Duarte, L. D. S., Uberti, A. F., Hohl, K. S., Follmer, C., & Carlini, C. R. (2023) · Microorganisms · doi:10.3390/microorganisms11082042 · Cited by 14
“The accumulation of α-synuclein and the death of dopaminergic neurons are hallmarks of Parkinson’s disease that culminate in motor deficits [19].”
BackgroundThe Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse
Vincent, B., & Shukla, M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230907151226 · Cited by 13
“Toll-like receptors play a crucial role in innate immunity, and dysregulation in their signaling may be implicated in α-synucleinopathy, such as in PD [470].”
BackgroundJiao, F., Zhou, L., & Wu, Z. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07878-x · Cited by 15
Giron, M. C., & Mazzi, U. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.11.002 · Cited by 14
Self-citationIs Gut Dysbiosis an Epicenter of Parkinson’s Disease?
Rajput, C., Sarkar, A., Sachan, N., Rawat, N., & Singh, M. P. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03187-9 · Cited by 14
Wu, P.-N., Xiong, S., Zhong, P., Yang, W., Chen, M., & Tang, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.956204 · Cited by 14
Metadata
- Authors
- Caputi, V., & Giron, M. C.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Giron, Maria Cecilia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-06-06
- Volume
- 19
- Issue
- 6
- Pages
- 1689
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6032048
- OpenAlex
- W2807153072
- Cited by
- 338
- References
- 140
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 57 · 2021: 69 · 2020: 43 · 2019: 29 · 2018: 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Università degli Studi di Padova (PRID Grant 2017, Assegno di Ricerca 2016)
- San Camillo Hospital, Treviso (Italy) (Grant 2015)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, microbiota-gut-brain axis, Toll-like receptors, synucleinopathies, gut dysbiosis, small intestinal bacterial overgrowth, intestinal permeability, innate immunity, neuroinflammation, gastrointestinal dysfunction, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Brain, Humans, Immunity, Innate, Parkinson Disease, Probiotics, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.